A Randomized Controlled Phase 2 Trial of the Blood Stage AMA1-C1/Alhydrogel Malaria Vaccine in Children in Mali

A double blind, randomized, controlled Phase 2 clinical trial was conducted to assess the safety, immunogenicity, and biologic impact of the vaccine candidate Apical Membrane Antigen 1- Combination 1 (AMA1-C1), adjuvanted with Alhydrogel(®). Participants were healthy children 2-3 years old living in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sagara, Issaka, Dicko, Alassane, Ellis, Ruth D., Fay, Michael P., Diawara, Sory I., Assadou, Mahamadoun H., Sissoko, Mahamadou S., Kone, Mamady, Diallo, Abdoulbaki I., Saye, Renion, Guindo, Merepen A., Kante, Ousmane, Niambele, Mohamed B., Miura, Kazutoyo, Mullen, Gregory E.D., Pierce, Mark, Martin, Laura B., Dolo, Amagana, Diallo, Dapa A., Doumbo, Ogobara K, Miller, Louis H, Saul, Allan
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713037/
https://ncbi.nlm.nih.gov/pubmed/19428923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.03.014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares